UMMS Affiliation

Commonwealth Medicine, Clinical Pharmacy Services

Publication Date

11-16-2016

Document Type

Presentation

Disciplines

Health Economics | Health Law and Policy | Health Policy | Health Services Administration | Health Services Research | Pharmacoeconomics and Pharmaceutical Economics | Pharmacy Administration, Policy and Regulation

Abstract

Specialty drug spend increased by 15 percent to $121 billion in 2015 and is projected to rise even more. Budget-conscious payers need to implement novel management strategies that anticipate the cost of specialty medications before they’re available. A summary of efficacy data for high-impact specialty pipeline drugs expected to reach the market, including their place in therapy and budgetary impact. Also featured are strategies to mitigate costs of these cutting-edge medications and compare them to current therapy options.

Keywords

specialty medications, specialty drugs, drug spend, pharmacy, drug utilization review

Journal/Book/Conference Title

Eastern Medicaid Pharmacy Administrators Association 40th Annual Meeting

Comments

Presented at the Eastern Medicaid Pharmacy Administrators Association 40th Annual Meeting.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.